Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

416 ARTÍCULOS , VIENDO DEL 196 AL 210

Can we influence the epidemiology of dementia? Perspectives from population-based studies

Birdi R, Stephan BC, Robinson L, Davis D.

Postgrad Med J. 2015 Nov;91(1081):651-4. doi: 10.1136/postgradmedj-2015-133244. Epub 2015 Aug 31.

Interventions for Neuropsychiatric Symptoms in Neurocognitive Impairment Due to Alzheimer's Disease: A Review of the Literature

McClam TD, Marano CM, Rosenberg PB, Lyketsos CG.

Harv Rev Psychiatry. 2015 Sep-Oct;23(5):377-93. doi: 10.1097/HRP.0000000000000097.

Current Developments in Dementia Risk Prediction Modelling: An Updated Systematic Review

Tang EY, Harrison SL, Errington L, Gordon MF, Visser PJ, Novak G, Dufouil C, Brayne C, Robinson L, Launer LJ, Stephan BC.

PLoS One. 2015 Sep 3;10(9):e0136181. doi: 10.1371/journal.pone.0136181. eCollection 2015.

Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services

Wattmo C, Londos E, Minthon L.

Dement Geriatr Cogn Disord. 2015;40(5-6):297-310. doi: 10.1159/000437050. Epub 2015 Sep 4.

Alcohol Consumption, Dementia and Cognitive Decline: An Overview of Systematic Reviews

Ilomaki J, Jokanovic N, Tan EC, Lonnroos E.

Curr Clin Pharmacol. 2015;10(3):204-12. doi: 10.2174/157488471003150820145539.

Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline

Walker JM, Harrison FE.

Nutrients. 2015 Sep 1;7(9):7332-57. doi: 10.3390/nu7095341.

Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease?

Dekker AD, Strydom A, Coppus AM, Nizetic D, Vermeiren Y, Naudé PJ, Van Dam D, Potier MC, Fortea J, De Deyn PP.

Cortex. 2015 Dec;73:36-61. doi: 10.1016/j.cortex.2015.07.032. Epub 2015 Aug 13.

Alzheimer's disease and language impairments: social intervention and medical treatment

Klimova B, Maresova P, Valis M, Hort J, Kuca K.

Clin Interv Aging. 2015 Aug 27;10:1401-7. doi: 10.2147/CIA.S89714. eCollection 2015.

Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer

Bailly M, Destrieux C, Hommet C, Mondon K, Cottier JP, Beaufils E, Vierron E, Vercouillie J, Ibazizene M, Voisin T, Payoux P, Barré L, Camus V, Guilloteau D, Ribeiro MJ.

Biomed Res Int. 2015;2015:583931. doi: 10.1155/2015/583931. Epub 2015 Jun 17.

Treatment Options in Alzheimer´s Disease: The GABA Story

Solas M, Puerta E, Ramirez MJ.

Curr Pharm Des. 2015;21(34):4960-71. doi: 10.2174/1381612821666150914121149.

Neurogranin Levels in Cerebrospinal Fluid: A New Addition to the Alzheimer Disease Diagnostic Toolbox

Zetterberg H, Blennow K.

JAMA Neurol. 2015 Nov;72(11):1237-8. doi: 10.1001/jamaneurol.2015.2075.

Informed Consent Challenges in Frail, Delirious, Demented, and Do-Not-Resuscitate Adult Patients

Requarth JA.

J Vasc Interv Radiol. 2015 Nov;26(11):1647-51. doi: 10.1016/j.jvir.2015.08.011. Epub 2015 Sep 11.

The Effect of Aroma Hand Massage Therapy for People with Dementia

Yoshiyama K, Arita H, Suzuki J.

J Altern Complement Med. 2015 Dec;21(12):759-65. doi: 10.1089/acm.2015.0158. Epub 2015 Sep 18.

Progresses in treating agitation: a major clinical challenge in Alzheimer's disease

Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Santamato A, Lozupone M, Prete C, Greco A, Pilotto A, Logroscino G.

Expert Opin Pharmacother. 2015;16(17):2581-8. doi: 10.1517/14656566.2015.1092520. Epub 2015 Sep 21.

Dextromethorphan and Quinidine for Treating Agitation in Patients With Alzheimer Disease Dementia

Ballard C, Sharp S, Corbett A.

JAMA. 2015 Sep 22-29;314(12):1233-5. doi: 10.1001/jama.2015.10215.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias